Fox Chase Cancer Center Welcomes Dr. Qing Chen

Press Release Thumbnail
Qing Chen, MD, PhD, as an Assistant Professor in the Cancer Signaling and Microenvironment Research Program.

PHILADELPHIA (January 9, 2025) — Fox Chase Cancer Center is pleased to announce the hiring of Qing Chen, MD, PhD, as an Assistant Professor in the Cancer Signaling and Microenvironment Research Program.

Chen joins Fox Chase from the Wistar Institute in Philadelphia, where she was an Assistant Professor in the Genome Regulation and Cell Signaling Program at the Ellen and Ronald Caplan Cancer Center and Scientific Director of the Imaging Facility.  

The Cancer Signaling and Microenvironment Research Program studies signaling processes, their cancer cell-intrinsic adaptation, and how they are affected by extrinsic cell-to-cell communication components of the microenvironment. The program aims to better understand cancer biology by viewing cancer cells and their environment, aiding in the creation of new strategies for attenuating these signals, and helping serve patients.  

Chen received her medical degree and a Master of Science degree in molecular neurobiology from Capital University of Medical Sciences in Beijing. She went on to earn a doctorate in immunology at the State University of New York at Buffalo. Chen also completed postdoctoral fellowships at Roswell Park Cancer Institute and Memorial Sloan-Kettering Cancer Center.  

Chen’s research explores cancer metastasis by investigating the spread of cancer cells to the brain. It focuses on the interactions between cancer cells and the unique cells of the brain microenvironment. The goal of her lab is to discover mechanisms that could lead to effective therapies for brain metastasis.  

Chen has earned several honors throughout her career, including the Melanoma Research Program Idea Award from the U.S. Department of Defense, the National Cancer Institute Transition Career Development Award, the Howard Hughes Medical Institute-Sponsored Postdoctoral Fellowship, and the Susan G. Komen Career Catalyst Award.

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427